Series 1 Schedule

1.5 From smallpox to COVID-19: Vaccine development & innovation

6th October 2020 as part of the FIP PSWC 2020

13:00-14:00 CEST


FIP is excited to announce a new initiative entitled “Transforming Vaccination Globally and Regionally.” This initiative involves a three-part series of 8 online events each, and is the first FIP transformational outcome-based online programme of its kind, culminating in the signing of a historical commitment by FIP and member organisations to transform vaccinations globally and regionally.

In this episode – “From Smallpox to COVID-19: Vaccine Development & Innovation,” panellists with expertise in pharmaceutical sciences discuss the history and the future of vaccination; how vaccines are developed; the difficulties in developing vaccines for emerging diseases; and the impact this has on the ability to deliver new vaccines to populations in a timely manner. Panellists will discuss current research and where this is heading in the near future; recent developments in vaccine production & logistics; and how COVID has impacted on vaccine delivery and uptake worldwide.

The event will feature a special feature segment with Ronald T. Piervincenzi, CEO, United States Pharmacopeia (USP), USA. In addition, FIP CEO Catherine Duggan will lead a discussion with Ross McKinnon and Giovanni Pauletti to identify key take-aways & needs to transform vaccination through pharmaceutical sciences and what FIP can do to progress this journey.



  • Ross McKinnon – (Strategic Professor in Cancer Research & Mathew Flinders Distinguished Professor, College of Medicine and Public Health, College of Medicine and Public Health, Australia)
  • Giovanni Pauletti – (FIP Scientific Secretary, St. Louis College of Pharmacy, USA)
  • Ronald T. Piervincenzi – (CEO- United States Pharmacopeia USP, USA)

Event Details

You can watch the event recording here.

Download event slides

Sponsored by Pfizer